The previous page is sending you to http://www.marketwatch.com/story/ventrus-biosciences-announces-positive-results-from-pivotal-phase-3-trial-of-diltiazem-ven-307-in-patients-with-anal-fissures-2012-05-14.

 If you do not want to visit that page, you can return to the previous page.